1IC
GILD icon

1919 Investment Counsel’s Gilead Sciences GILD Stock Holding History

1919 Investment Counsel’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$87.1M Sell
818,657
-34,466
-4% -$3.37M 1.79% 3
2014
Q2 		$70.7M Sell
853,123
-46,487
-5% -$3.62M 1.44% 9
2014
Q1 		$63.7M Sell
899,610
-51,319
-5% -$4.02M 1.3% 12
2013
Q4 		$71.4M Sell
950,929
-30,068
-3% -$2.09M 1.49% 8
2013
Q3 		$61.7M Sell
980,997
-34,924
-3% -$2.09M 1.39% 11
2013
Q2 		$52.1M Buy
+1,015,921
New +$53M 1.22% 19

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

1919 Investment Counsel's GILD Position: Q3 2014 in Review

1919 Investment Counsel reduced its Gilead Sciences (GILD) stake by 4% in Q3 2014, selling an estimated $3.37M and leaving 818,657 shares worth $87.1M. The position accounts for 1.79% of the portfolio, ranked #3.

1919 Investment Counsel first reported a position in GILD in Q2 2013 and has held it in 6 quarters since. 1,327 funds tracked by Wall St. Rank hold GILD as of Q3 2014.

  • 1919 Investment Counsel held 818,657 shares of Gilead Sciences worth $87.1M as of Q3 2014.
  • 1919 Investment Counsel sold 34,466 Gilead Sciences shares in Q3 2014, an estimated $3.37M.
  • Gilead Sciences made up 1.79% of 1919 Investment Counsel's portfolio in Q3 2014, its #3 holding.
  • 1919 Investment Counsel first reported a position in Gilead Sciences in Q2 2013 and has held it in 6 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.